| Literature DB >> 497409 |
Abstract
By treatment of the mouse leukemia L 1210 with cytosinarabinoside (120 mg/kg per week) a tumour cell line was developed which was resistant to this cytostatic agent. It is possible, using the short-term test, to follow the development of resistance to cytosinarabinoside.Entities:
Mesh:
Substances:
Year: 1979 PMID: 497409 DOI: 10.1007/bf01013223
Source DB: PubMed Journal: Blut ISSN: 0006-5242